INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Open-market saleVerified dataRule 10b5-1 plan

Ribeiro Ramiro sold EYPT

Chief Medical Officer · EyePoint, Inc. · Common Stock

Side
SELL
Value
$44K
Shares
2,438
Price
$17.87
Executed
Mar 4, 2026
Disclosed
Mar 5, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Mar 4 executedMar 5, 2026 disclosed

EYPT · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
13/ 100 · ROUTINE
Methodology →
  • Transaction type+6 / 20

    Open-market sale

  • Relative size+13 / 25

    $44K reported value · 100.0% of prior position

  • Filing timing0 / 15

    Disclosed 1 business day after execution (deadline: 2)

  • Historical behavior+4 / 15

    3 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • Pre-arranged plan-10

    Executed under a Rule 10b5-1 trading plan

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · EYPT

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,437 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    13
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,438 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,437 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,438 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,437 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    7
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,438 sh
    		Jun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dSEC FORM 4

    Evidence

    13
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,437 sh
    		Apr 17, 2026Apr 20, 2026
    traded Apr 17, 2026
    		+3dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,437 sh
    		Apr 17, 2026Apr 20, 2026
    traded Apr 17, 2026
    		+3dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,437 sh
    		Apr 17, 2026Apr 20, 2026
    traded Apr 17, 2026
    		+3dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,438 sh
    		Mar 4, 2026Mar 5, 2026
    traded Mar 4, 2026
    		+1dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,438 sh
    		Mar 4, 2026Mar 5, 2026
    traded Mar 4, 2026
    		+1dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$20K
    2,437 sh
    		Feb 17, 2026Feb 18, 2026
    traded Feb 17, 2026
    		+1dSEC FORM 4

    Evidence

    13
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$37K
    2,437 sh
    		Feb 17, 2026Feb 18, 2026
    traded Feb 17, 2026
    		+1dSEC FORM 4

    Evidence

    0
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    2,437 sh
    		Feb 17, 2026Feb 18, 2026
    traded Feb 17, 2026
    		+1dSEC FORM 4

    Evidence

    10
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M$242K
    29.3K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    19
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$727K
    42.5K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    7
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise · 10b5-1 plan
    		M—
    29.3K sh
    		Jan 5, 2026Jan 7, 2026
    traded Jan 5, 2026
    		+2dSEC FORM 4

    Evidence

    9
    DS
    Duty StuartDirector
    EYPTEyePoint, Inc.
    Grant or award
    		A—
    40.0K sh
    		Jan 2, 2026Jan 6, 2026
    traded Jan 2, 2026
    		+4dSEC FORM 4

    Evidence

    5
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Option exercise
    		M—
    19.7K sh
    		Jan 3, 2026Jan 6, 2026
    traded Jan 3, 2026
    		+3dSEC FORM 4

    Evidence

    20
    RR
    Ribeiro RamiroChief Medical Officer
    EYPTEyePoint, Inc.
    Tax withholding
    		F$111K
    6,373 sh
    		Jan 3, 2026Jan 6, 2026
    traded Jan 3, 2026
    		+3dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002013623-26-000008
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 4, 2026
    Published
    Mar 5, 2026
    Ingested by INSIDER
    Nov 5, 04:13 UTC
    Last re-read
    Nov 5, 04:13 UTC

    Extracted facts

    Filer
    Ribeiro Ramiro
    Role
    Chief Medical Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    EyePoint, Inc.
    Ticker
    EYPT
    Shares
    2,438
    Price per share
    $17.87
    Value
    $43,572
    Execution date (reported)
    Mar 4, 2026
    Owned after transaction
    0 shares
    Rule 10b5-1 plan
    Yes, as checked by the filer
    Days from execution to publication
    1

    Calculation

    Value = shares × reported price per share

    • Shares: 2,438
    • Price: $17.8719

    = $43,572

    What this establishes

    Ribeiro Ramiro filed this Form 4 reporting a open-market sale of EYPT on Mar 4, 2026. It became public on Mar 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    Chief Medical Officer
    Ribeiro Ramirocik:0002013623
    Issuer
    EyePoint, Inc.cik:0001314102

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.